RECENT PLACEMENT

Occam Places Jeff Goater as Board Chair of AviadoBio

Occam Places Jeff Goater as Board Chair of AviadoBio

AviadoBio, a pre-clinical stage platform company with operations in the UK and the US and backed by NEA, F-Prime, and J&J Innovation and focused on developing and delivering transformative gene therapies for people with neurodegenerative disorders, has appointed Jeff Goater as Chair of its Board of Directors.

Jeff brings more than 20 years of biotech and Wall Street experience to this appointment. Currently, Jeff is a Venture Partner at The Column Group and interim CEO of Atavistik Bio. Previous roles include CEO of Surface Oncology and Managing Director at Evercore Partners.

Jeff holds graduate degrees in immunology, pathology, and business administration from the University of Rochester. He currently serves on the boards of Atavistik, Judo Bio, Kallyope, Ribon Therapeutics, and Surface Oncology.

With Occam having also placed Lisa Deschamps as CEO at AviadoBio in 2021, we are pleased to extend our relationship at the Board level.

‍

Recent Placements

  1. Bastiano Sanna as CEO of Semma
  2. Bill Brondyk as CSO at Invetx
  3. Aron Feingold as VP of Investor Relations & Corporate Communications at Geron
  4. Brian Goldman as Chief Computation Officer at ZebiAI
  5. Ann Taylor as Board Member at Comanche Biopharma
About Occam Global

Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.